Pathware

About Pathware

Pathware is a medical technology company developing hardware and software to bring digital pathology to the point-of-care. Founded in 2016 and headquartered in Golden, Colorado, the company aims to address the high rate of inconclusive biopsies, which can be as high as 20-25% due to inadequate sample quality. This issue often forces patients to undergo repeat procedures, causing delays in diagnosis and increased healthcare costs. The company's co-founders are Michael Moore and Jaron Nix. In April 2022, Pathware appointed MedTech veteran TJ Meyer as CEO.

Pathware's core product is the Bioptic™ system, a platform that combines hardware and software to simplify and accelerate digital pathology workflows. The system provides rapid, whole-slide imaging and uses a cloud-based management platform to deliver a biopsy quality assessment in minutes, often while the patient is still present. By integrating computational microscopy and AI, the Bioptic™ platform analyzes tissue samples to verify that a viable sample has been collected with high certainty, enabling clinicians to determine if another sample is needed immediately. This intervention at the point-of-care is designed to reduce the need for repeat procedures, improve patient outcomes, and decrease diagnostic times.

The company's business model targets hospitals and clinics, offering a solution to the challenges of performing Rapid Onsite Evaluation (ROSE), which is often hampered by a shortage of available pathologists. Pathware's system aims to increase clinical revenues and workflow efficiency for pathologists and proceduralists, allowing for earlier cancer diagnosis. The firm has successfully raised capital to fund its expansion and seek FDA clearance for its integrated system. A significant milestone was the closing of an oversubscribed $7 million Series A financing round in April 2022, led by UnityPoint Health Ventures and Level Eight Ventures. Total funding has reached over $8.46 million through multiple rounds, including grants from organizations like the National Science Foundation.